Skip to main content
Skip to main content
ONSS logo

Onassis Holdings Corp. (ONSS) Stock Analysis

$0.0003 +$0.000099 (+49.25%)
Vol: 100| 52-wk range: $0.0001 – $0.01
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Onassis Holdings Corp. (ONSS) trades at $0.0003. Onassis Holdings Corp. operates in the wellness, cannabidiol (CBD) and hemp oil, and cosmetics industries, providing products and services to businesses in the United States and Europe. Sector: Healthcare.

Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026
Onassis Holdings Corp. operates in the wellness, cannabidiol (CBD) and hemp oil, and cosmetics industries, providing products and services to businesses in the United States and Europe. The company also develops and markets electronic disinfection devices, reflecting a diversified approach to health and wellness solutions.

Analyst Coverage for ONSS: ONSS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ONSS against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the ONSS film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Not yet rated

Not enough scored data yet to form a council read on ONSS.

How is this calculated? →
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Onassis Holdings Corp. (ONSS) Healthcare & Pipeline Overview

CEOEliron Yaron
HeadquartersNew York City, US
IPO Year2013

Onassis Holdings Corp. focuses on the wellness, CBD, hemp oil, and cosmetics sectors, offering products and services to businesses in the US and Europe. The company's diversification into electronic disinfection devices positions it within the evolving health and wellness landscape, though it faces competition from established players.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for ONSS?

As of Mar 18, 2026 — figures reflect the data available on that date.

Onassis Holdings Corp. presents a speculative investment opportunity within the high-growth CBD and wellness markets. The company's diversification into electronic disinfection devices adds another potential revenue stream. However, the company's financial performance and OTC market listing raise concerns. Key value drivers include successful product development and market penetration in the CBD and disinfection sectors. Upcoming catalysts include potential partnerships and regulatory developments in the CBD industry. The company's beta of 0.46 suggests lower volatility compared to the broader market. However, the negative P/E ratio of -0.18 indicates unprofitability. Investors should carefully assess the company's financial stability, competitive positioning, and regulatory risks before considering an investment.

Based on FMP financials and quantitative analysis

ONSS Key Highlights

Onassis Holdings Corp. operates in the high-growth CBD and wellness markets, presenting potential for revenue expansion.

  • The company's diversification into electronic disinfection devices offers a secondary revenue stream and aligns with current health trends.
  • The company's rebranding in 2019 signaled a strategic shift towards the health and wellness sectors.
  • Onassis Holdings Corp. serves businesses in the United States and Europe, providing geographic diversification.
  • The company's beta of 0.46 suggests lower volatility compared to the broader market, but its negative P/E ratio of -0.18 indicates unprofitability.

Who Are ONSS's Competitors?

ONSS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
INNPF INNOCAN PHARMA Corp $1.60 -8.05% $7.20M 61
GENH Generation Hemp, Inc. $0.22 +0.00% $25.3M 63
GBLP Global Pharmatech, Inc. $0.08 +0.00% $33.3M 62
ETST Earth Science Tech, Inc. $0.12 +14.45% $35.3M 61
GDNSF Goodness Growth Holdings, Inc. $0.45 +0.00% $61.1M 64
MNNGF Baijin Life Science Holdings Limited $0.08 +0.00% $74.6M 63
SHIEF Shield Therapeutics plc $0.07 +0.00% $75.3M 62
CNVCF BioHarvest Sciences Inc. $6.30 +0.00% $109M 66

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ONSS's Key Strengths?

Diversified product portfolio across CBD, hemp oil, and disinfection devices.

  • Established presence in the US and European markets.
  • Focus on providing products and services to businesses in the CBD industry.
  • Strategic shift towards high-growth wellness and healthcare sectors.

What Are ONSS's Weaknesses?

OTC market listing raises concerns about liquidity and regulatory oversight.

  • Negative P/E ratio indicates unprofitability.
  • Limited brand recognition compared to established players.
  • Reliance on the evolving and uncertain regulatory landscape for CBD products.

What Could Drive ONSS Stock Higher?

ONSS catalyst: Potential partnerships with established players in the healthcare, cosmetics, and retail industries to expand market reach.

  • Development of innovative CBD and disinfection products to drive revenue growth and enhance competitive advantage.
  • Expansion into new geographic markets with high growth potential in the CBD and wellness sectors.
  • Capitalizing on the growing demand for hygiene and sanitation solutions through electronic disinfection devices.
  • Focus on e-commerce and direct-to-consumer sales to enhance brand visibility and improve profit margins.

What Are the Key Risks for ONSS?

Financial-distress signal — its Altman Z-Score of -36.39 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Intense competition from established players in the pharmaceutical, cosmetics, and disinfection industries.
  • Regulatory uncertainty surrounding CBD products.
  • Adverse health effects associated with CBD use.
  • Fluctuations in commodity prices for hemp and other raw materials.
  • Limited liquidity and price volatility due to OTC Other tier listing.

What Are the Growth Opportunities for ONSS?

  • Expansion into New Geographies: Onassis Holdings Corp. can expand its market reach by targeting new geographic regions with high growth potential in the CBD and wellness sectors. This includes exploring opportunities in Asia-Pacific and Latin America, where consumer demand for wellness products is increasing. Successful expansion requires adapting products to local preferences and navigating regulatory requirements in each new market. Timeline: Within the next 2-3 years.
  • Development of Innovative Products: Investing in research and development to create innovative CBD and wellness products can drive revenue growth and enhance Onassis Holdings Corp.'s competitive advantage. This includes developing novel formulations, delivery methods, and applications for CBD. The company can also explore opportunities in personalized wellness solutions tailored to individual consumer needs. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: Forming strategic partnerships with established players in the healthcare, cosmetics, and retail industries can accelerate market penetration and expand Onassis Holdings Corp.'s distribution network. Acquisitions of complementary businesses can provide access to new technologies, products, and markets. Timeline: Ongoing.
  • Capitalizing on the Growing Demand for Disinfection Solutions: Onassis Holdings Corp. can leverage its expertise in electronic disinfection devices to capitalize on the growing demand for hygiene and sanitation solutions. This includes targeting hospitals, schools, offices, and other public spaces. The company can also develop innovative disinfection products for personal use. The global disinfection market is projected to reach $15.2 billion by 2027. Timeline: Ongoing.
  • Focus on E-Commerce and Direct-to-Consumer Sales: Expanding its online presence and focusing on direct-to-consumer sales can enhance Onassis Holdings Corp.'s brand visibility and improve profit margins. This includes investing in e-commerce platforms, digital marketing, and social media engagement. The company can also offer subscription-based wellness programs and personalized product recommendations. Timeline: Ongoing.

What Are ONSS's Competitive Advantages?

  • Diversified product portfolio across CBD, hemp oil, and disinfection devices.
  • Established presence in the US and European markets.
  • Focus on providing products and services to businesses in the CBD industry.

What Does ONSS Do?

Onassis Holdings Corp., headquartered in New York City, operates within the healthcare sector, specifically targeting the wellness, cannabidiol (CBD), hemp oil, and cosmetics industries. Originally established as Onassis Mining Group, Inc., the company rebranded in September 2019 to reflect its strategic shift towards health and wellness markets. Onassis Holdings Corp. provides a range of products and services to businesses operating in the CBD and hemp oil sectors across the United States and Europe. This includes raw materials, white-label products, and distribution support. In addition to its core focus on CBD and hemp, Onassis Holdings Corp. develops and markets electronic disinfection devices. This diversification aims to capitalize on the growing demand for hygiene and sanitation solutions, particularly in the wake of increased health awareness. The company's business model involves both direct sales and partnerships with other businesses in the wellness and healthcare space. Onassis Holdings Corp. seeks to establish a presence in the rapidly expanding CBD and wellness markets by offering a diversified product portfolio and catering to the needs of businesses operating in these sectors. However, the company faces competition from established players in the pharmaceutical, cosmetics, and disinfection industries, requiring it to differentiate itself through innovation, quality, and strategic partnerships.

What Products and Services Does ONSS Offer?

  • Provides products and services to businesses in the CBD and hemp oil industry.
  • Develops and markets electronic disinfection devices.
  • Offers raw materials for CBD product manufacturing.
  • Provides white-label CBD products for businesses.
  • Offers distribution support for CBD and hemp oil products.
  • Operates in the wellness and cosmetics industries.

How Does ONSS Make Money?

  • Sells products and services to businesses in the CBD and hemp oil industry.
  • Generates revenue from the sale of electronic disinfection devices.
  • Forms partnerships with other businesses in the wellness and healthcare space.

What Industry Does ONSS Operate In?

Onassis Holdings Corp. operates in the rapidly evolving wellness and CBD industries, which have experienced significant growth due to increasing consumer interest in alternative health solutions. The market is characterized by intense competition, with numerous companies vying for market share. Regulatory uncertainty surrounding CBD products remains a key challenge. Onassis Holdings Corp.'s diversification into electronic disinfection devices aligns with the growing demand for hygiene solutions. The company competes with established players in the pharmaceutical, cosmetics, and disinfection industries. Success depends on product innovation, effective marketing, and navigating the complex regulatory landscape.

Who Are ONSS's Key Customers?

  • Businesses operating in the CBD and hemp oil industry in the United States and Europe.
  • Healthcare providers and facilities seeking disinfection solutions.
  • Consumers interested in wellness and cosmetic products.
AI Confidence: 69% Updated: Mar 18, 2026
Net buying

Insider Activity

The most recent 3 insider filings for Onassis Holdings Corp. break down as 1 sales and 2 purchases. On net that is roughly 6K shares acquired (about $7K) — insiders putting money in tends to read as conviction.

ROE 123%

Key Financial Metrics

Return on equity for Onassis Holdings Corp. stands at 122.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -25.0%, showing how much profit it generates from its asset base. A current ratio of 0.61 means current liabilities exceed short-term assets, a liquidity point worth watching.

F-Score 2/9

Financial Health

Onassis Holdings Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -36.39 places it in the distress zone, a signal of elevated financial risk.

Company Profile

Onassis Holdings Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in New York City, US. The company is led by CEO Eliron Yaron. ONSS has traded publicly since 2013.

ONSS Financials

Fundamental Snapshot

Return on Equity (TTM)
+122.8%
Current Ratio
0.6

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in the company's future, indicating that key stakeholders believe in its growth potential.
  • Community sentiment has shifted positively, with discussions highlighting the company's innovative projects and operational improvements.
  • Market perception has been bolstered by recent strategic partnerships, which could enhance revenue streams and market presence.
  • Positive news coverage has amplified interest, with analysts noting the company's resilience in a challenging economic landscape.

Bear Case

  • Concerns about overall market volatility could negatively impact investor sentiment, leading to caution around the stock.
  • Some community members express skepticism regarding the sustainability of recent growth, citing potential operational risks.
  • Recent discussions have raised questions about competitive pressures in the industry, which could hinder market share expansion.
  • Insider selling activity has also been noted, leading to speculation about potential challenges ahead for the company.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

ONSS Latest News

No recent news available for ONSS.

ONSS Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ONSS.

Price Targets

Wall Street price target analysis for ONSS.

ONSS MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates ONSS 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Eliron Yaron

CEO

Eliron Yaron serves as the CEO of Onassis Holdings Corp. His background includes experience in business development and strategic management. He has been involved in guiding the company's transition from its previous focus as Onassis Mining Group to its current emphasis on the wellness, CBD, and disinfection sectors. His expertise lies in identifying growth opportunities and implementing strategies to capitalize on emerging market trends. Prior to joining Onassis Holdings Corp., Yaron held leadership positions in various companies, focusing on business expansion and operational efficiency.

Track Record: Under Eliron Yaron's leadership, Onassis Holdings Corp. has undergone a strategic transformation, shifting its focus from mining to the wellness and healthcare sectors. Key milestones include the rebranding of the company, the development of new CBD and disinfection products, and the expansion of its market presence in the United States and Europe. Yaron has focused on building partnerships and navigating the regulatory landscape for CBD products.

ONSS OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Onassis Holdings Corp. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may be subject to less regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information, price volatility, and illiquidity.

  • OTC Tier: OTC Other
Liquidity: Liquidity for ONSS is likely limited due to its listing on the OTC Other tier. This typically translates to lower trading volumes and wider bid-ask spreads, making it more difficult to buy or sell shares quickly without significantly impacting the price. Investors should be prepared for potential price volatility and execution challenges when trading ONSS.
OTC Risk Factors:
  • Limited liquidity due to OTC Other tier listing.
  • Potential for price volatility and wider bid-ask spreads.
  • Less regulatory oversight compared to major exchanges.
  • Unknown financial disclosure status increases information asymmetry.
  • Higher risk of fraud or manipulation compared to listed companies.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Assess the company's management team and their track record.
  • Evaluate the company's business model and competitive landscape.
  • Determine the company's revenue sources and growth potential.
  • Analyze the company's capital structure and debt levels.
  • Assess the company's compliance with regulatory requirements.
  • Consult with a financial advisor to understand the risks involved.
Legitimacy Signals:
  • Company's registration and good standing with relevant regulatory bodies.
  • Existence of a professional website and investor relations materials.
  • Presence of independent directors on the board.
  • Audited financial statements (if available).
  • Positive media coverage and industry recognition.

What Investors Ask About Onassis Holdings Corp. (ONSS) — Healthcare

What does Onassis Holdings Corp. do?

Onassis Holdings Corp. operates in the wellness, cannabidiol (CBD), hemp oil, and cosmetics industries. The company provides products and services to businesses operating in the CBD and hemp oil sectors across the United States and Europe. In addition to its core focus on CBD and hemp, Onassis Holdings Corp.

What do analysts say about ONSS stock?

There is currently no available analyst coverage or consensus for Onassis Holdings Corp. (ONSS) due to its OTC listing and limited market capitalization. Investors should conduct their own thorough research and due diligence before considering an investment in ONSS.

What are the main risks for ONSS?

The main risks for Onassis Holdings Corp. include intense competition from established players in the pharmaceutical, cosmetics, and disinfection industries, regulatory uncertainty surrounding CBD products, potential adverse health effects associated with CBD use, fluctuations in commodity prices for hemp and other raw materials, and limited liquidity and price volatility due to its OTC Other tier listing.

What are the key factors to evaluate for ONSS?

Evaluate ONSS on fundamentals, analyst consensus, and risk factors. Onassis Holdings Corp. presents a speculative investment opportunity within the high-growth CBD and wellness markets. Not financial advice.

How frequently does ONSS data refresh on this page?

ONSS's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven ONSS's recent stock price performance?

Onassis Holdings Corp. (ONSS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio across CBD, hemp oil, and disinfection devices. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ONSS overvalued or undervalued right now?

Onassis Holdings Corp. (ONSS) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research ONSS before investing?

Before investing in Onassis Holdings Corp. (ONSS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available company profile and financial data. The absence of recent financial reports and analyst coverage limits the depth of analysis.
  • OTC market investments carry higher risks due to limited liquidity and regulatory oversight.
Data Sources

Popular Stocks

More Stocks We Cover